Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy

Clinical Neurology

Volumn 36, Issue 1, 1996, Pages 7-11

  Kashiwagi, Setsuko ^a   Akaike, Masashi ^a   Kawai, Hisaomi ^a   Adachi, Katsuhito ^b   Saito, Shiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Yoshinogawa   (Japan)

Author keywords

brain natriuretic peptide (BNP); Duchenne muscular dystrophy; heart failure; plasma BNP concentration

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; HEART FAILURE; HEART FUNCTION; HEREDITARY SPINAL MUSCULAR ATROPHY; HUMAN; MAJOR CLINICAL STUDY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; HEART; HEART DISEASES; HUMANS; MALE; MUSCULAR DYSTROPHIES; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS;

EID: 0029995458     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gilroy J, Cahalan JL, Berman R, et al: Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy. Circulation 27: 484-493, 1963
2. Matsuda M, Akatsuka N, Yamaguchi T, et al: Systolic time intervals in patients with progressive muscular dystrophy of the Duchenne type. Jap Heart J 18: 638-651, 1977
3. Leth A, Wulff K: Myocardiopathy in Duchenne pro-gressive muscular dystrophy. Acta Pediatr Scand 65: 28-32, 1976
4. Kawai H, Adachi K, Kimura C, et al: Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy. Arch Neurol 47: 900-904, 1990
5. Anderson JV, Donckier J, McKenna WJ, et al: The plasma release of atrial natriuretic peptide in man. Clin Sci 71: 151-155, 1986
6. Tateyama II, Hino J, Minamoto N, et al: Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium. Biochem Biophys Res Commun 166: 1080-1087, 1990
7. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87: 1402-1412, 1991
8. Sudoh T, Kangawa K, Minamoto N, et al: A new natriuretic peptide in porcine brain. Nature 332: 78-81, 1988
9. Yoshimura M, Yasue H, Morita E, et al: Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84: 1581-1588, 1991
10. Sugita H, Arahata K, Ishiguro T, et al: Negative immunostaining of Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA. Proc Japan Acad 64(B): 37-39, 1988
11. Chamberlain JS, Gibbs RA, Ranier JE, et al: Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16: 11141-11156, 1988
12. Beggs AH, Koenig M, Boyce FM, et al: Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86: 45-48, 1990
13. Tsuji T, Imagawa H, Masuda H, et al: Stabilization of human brain natriuretic peptide in blood samples. Clin Chem 40: 672-673, 1994
14. Nielsen L, Ludvigsen B. Improved method for determination of creatine kinase. J Lab Clin Med 62: 159-168, 1963
15. Mattioli L, Melhorn M: Duchcnne's muscular dystrophy. The diagnosis and management of cardiac involvement. J Kans Med Soc 83: 115-121, 1982